Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis

por Ryan, P, McBride, A, Ray, D, Pulgar, S, Ramirez, RA, Elquza, E, Favaro, JP, Dranitsaris, G
Publicado 2019